Methods A systematic literature search was conducted to identify studies evaluating
pharmacological strategies to prevent AF published between 1966 and November 2007 …

Study Objectives. To assess the efficacy of 3‐hydroxy‐3‐methylglutaryl coenzyme A
reductase inhibitors (statins) for primary and secondary prevention of atrial fibrillation, and to …

Atrial fibrillation is one of the most frequent heart rhythm disturbances found in clinical
practice. Anticoagulation, rate control, cardioversion, and ablative procedures have been the …

The inhibition of the renin‐angiotensin system has demonstrated both experimental and
clinical effects in preventing atrial fibrillation. However, there is still uncertainty about the role …

Background A number of clinical and experimental studies have investigated the effect of
atorvastatin on atrial fibrillation (AF), but the results are equivocal. This meta-analysis was …

Background: Impact of atrial fibrillation on clinical outcomes is well recognized, and
application of renin–angiotensin–aldosterone system (RAAS) blockers for the prevention of …

Background: Controversy persists regarding the efficacy of angiotensin-converting enzyme
inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in the prevention of recurrent …

Objectives: This study was designed to identify all randomized clinical trial data evaluating
angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for the prevention …

The therapy or prevention of atrial fibrillation (AF) is defined as upstream therapy when
conducted with the use of drugs, eg, angiotensin-converting enzyme inhibitors (ACEIs) …

Objectives: The authors reviewed published clinical trial data on the effects of renin-
angiotensin system (RAS) inhibition for the prevention of atrial fibrillation (AF), aiming to …